Cardiff Oncology announces special shareholder meeting
CRDF•Common stock authorization would increase
Under the proposal, common stock authorization would increase to 300,000,000 shares from 150,000,000.
Adjournment proposal if more time is needed
A separate proposal seeks approval to adjourn the meeting if more time is needed to solicit votes for the share increase.
Special stockholder meeting planned in San Diego
Cardiff Oncology plans a special stockholder meeting in San Diego in October 2026.
The company said stockholders will vote on amending the certificate of incorporation to raise authorized capital stock to 320,000,000 shares from 170,000,000.
